Development of [64Cu]-DOTA-anti-CD20 for targeted therapy

A. R. Jalilian, L. Mirsadeghi, Y. Yari-Kamrani, P. Rowshanfarzad, M. Kamali-Dehghan, M. Sabet

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


Dive into the research topics of 'Development of [64Cu]-DOTA-anti-CD20 for targeted therapy'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology


Agricultural and Biological Sciences

Immunology and Microbiology

Chemical Engineering